Odonate Therapeutics
Odonate, Inc., has no significant operations. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
Odonate Therapeutics - Asset Resilience Ratio
Odonate Therapeutics (ODTC) has an Asset Resilience Ratio of 36.13% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2023)
This chart shows how Odonate Therapeutics's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Odonate Therapeutics's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $37.48 Million | 36.13% |
| Total Liquid Assets | $37.48 Million | 36.13% |
Asset Resilience Insights
- Very High Liquidity: Odonate Therapeutics maintains exceptional liquid asset reserves at 36.13% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Odonate Therapeutics Industry Peers by Asset Resilience Ratio
Compare Odonate Therapeutics's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Itokk Inc
PINK:IKTO |
Shell Companies | 0.00% |
|
Cuspis Capital II Ltd
V:CCII-P |
Shell Companies | 97.65% |
|
Aloys Inc.
KQ:297570 |
Shell Companies | 1.22% |
|
Nh Special Purpose Acquisition 14 Co. Ltd
KQ:319400 |
Shell Companies | 1.35% |
|
Ibkimyoung Co. Ltd
KQ:339950 |
Shell Companies | 25.20% |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880 |
Shell Companies | 93.60% |
|
464680
KQ:464680 |
Shell Companies | 97.32% |
Annual Asset Resilience Ratio for Odonate Therapeutics (2021–2023)
The table below shows the annual Asset Resilience Ratio data for Odonate Therapeutics.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 15.82% | $17.48 Million | $110.45 Million | -20.31pp |
| 2022-12-31 | 36.13% | $37.48 Million | $103.73 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $79.00 Million | -- |